✦ LIBER ✦

Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial

✍ Scribed by P Noel Barrett; Gregory Berezuk; Sandor Fritsch; Gerald Aichinger; Mary Kate Hart; Wael El-Amin; Otfried Kistner; Hartmut J Ehrlich

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of 2009 pandem

✍ Xiao-Feng Liang; Hua-Qing Wang; Jun-Zhi Wang; Han-Hua Fang; Jiang Wu; Feng-Cai Z 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 161 KB

Safety and immunogenicity of a Vero-cell

✍ E Tauber; H Kollaritsch; M Korinek; P Rendi-Wagner; B Jilma; C Firbas; S Schranz 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 156 KB

Safety and immunogenicity of new cell-cu

✍ Richard N Greenberg; Jeffrey S Kennedy; David J Clanton; Elizabeth A Plummer; Ly 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 243 KB

Safety and immunogenicity of a trivalent

✍ Scott A Halperin; Bruce Smith; Taoufik Mabrouk; Marc Germain; Pierre Trépanier; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Immunogenicity and Safety in Adults of a

✍ J. Lang; J.C. Cetre; N. Picot; M. Lanta; P. Briantais; S. Vital; V. Le Mener; C. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Efficacy and safety of leuprorelin in pa

✍ Masahisa Katsuno; Haruhiko Banno; Keisuke Suzuki; Yu Takeuchi; Motoshi Kawashima 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 232 KB